Basisstatistiken
| CIK | 1254419 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to MedAssets, Inc.
SEC Filings (Chronological Order)
Auf dieser Seite finden Sie eine vollständige, chronologische Liste der SEC-Einreichungen, mit Ausnahme der Eigentumseinreichungen, die wir an anderer Stelle bereitstellen.
| February 16, 2016 |
MDAS / MedAssets, Inc. / Litespeed Management, L.L.C. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 10, 2016 |
MedAssets Form SC 13G/A (Acquisition of More Than 5% of Shares) medassetsinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2 )* Name of issuer: MedAssets Inc Title of Class of Securities: Common Stock CUSIP Number: 584045108 Date of Event Which Requires Filing of this Statement: December 31, 2015 Check the appropriate box to design |
|
| February 10, 2016 |
MDAS / MedAssets, Inc. / VANGUARD GROUP INC Passive Investment medassetsinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2 )* Name of issuer: MedAssets Inc Title of Class of Securities: Common Stock CUSIP Number: 584045108 Date of Event Which Requires Filing of this Statement: December 31, 2015 Check the appropriate box to design |
|
| February 8, 2016 |
15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 Certification and Notice of Termination of Registration under Section 12(g) of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under Sections 13 and 15(d) of the Securities Exchange Act of 1934. Commission File Number: 001-33881 MedAssets, Inc. (Exact name of co-registrants as specified |
|
| February 8, 2016 |
15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 Certification and Notice of Termination of Registration under Section 12(g) of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under Sections 13 and 15(d) of the Securities Exchange Act of 1934. Commission File Number: 001-33881 MedAssets, Inc. (Exact name of registrant as specified in |
|
| February 8, 2016 |
15-15D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 Certification and Notice of Termination of Registration under Section 12(g) of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under Sections 13 and 15(d) of the Securities Exchange Act of 1934. Commission File Number: 333-175729 Subsidiary Guarantors Listed On Schedule A Hereto (Exact |
|
| February 5, 2016 |
MDAS / MedAssets, Inc. / BROWN CAPITAL MANAGEMENT LLC Passive Investment SC 13G/A 1 fp0017921sc13ga.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 6)* MedAssets Inc. (Name of Issuer) Common Stock, Par Value $0.01 (Title of Class of Securities) 584045108 (CUSIP Number) Dece |
|
| February 5, 2016 |
MDAS / MedAssets, Inc. / BROWN CAPITAL MANAGEMENT LLC Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 7)* MedAssets Inc. (Name of Issuer) Common Stock, Par Value $0.01 (Title of Class of Securities) 584045108 (CUSIP Number) January 31, 2016 (Date of Event Whi |
|
| January 27, 2016 |
S-8 POS 1 d81136ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on January 27, 2016 Registration No. 333-148968 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 51-0391128 (S |
|
| January 27, 2016 |
S-8 POS As filed with the Securities and Exchange Commission on January 27, 2016 Registration No. |
|
| January 27, 2016 |
S-8 POS 1 d81136ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on January 27, 2016 Registration No. 333-191537 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 51-0391128 (S |
|
| January 27, 2016 |
Amended and Restated Certificate of Incorporation of MedAssets, Inc. EX-3.1 Exhibit 3.1 Amended and Restated Certificate of Incorporation of MedAssets, Inc. FIRST: The name of the corporation (which is hereinafter referred to as the ?Corporation?) is MedAssets, Inc. SECOND: The name and address of the registered agent of the Corporation in the State of Delaware is Corporation Service Company, 2711 Centerville Road, Suite 400, Wilmington, New Castle County, DE 19808 |
|
| January 27, 2016 |
Pamplona Capital Management Completes Acquisition of MedAssets for $2.75 Billion EX-99.1 Exhibit 99.1 Pamplona Capital Management Completes Acquisition of MedAssets for $2.75 Billion ATLANTA January 27, 2016 MedAssets, Inc. (NASDAQ: MDAS), a leading healthcare performance improvement company that serves four out of every five hospitals in the United States, announced that Pamplona Capital Management, LLP completed its acquisition of MedAssets today. MedAssets stock will s |
|
| January 27, 2016 |
S-8 POS 1 d81136ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on January 27, 2016 Registration No. 333-156505 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 51-0391128 (S |
|
| January 27, 2016 |
8-K 1 d87152d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 27, 2016 MedAssets, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-33881 51-0391128 (State or Other Jurisdiction of Inco |
|
| January 27, 2016 |
MEDASSETS, INC. ARTICLE I MEETING OF STOCKHOLDERS EX-3.2 Exhibit 3.2 MEDASSETS, INC. BY-LAWS ARTICLE I MEETING OF STOCKHOLDERS Section 1. Place of Meeting. Meetings of the stockholders of MedAssets, Inc. (the ?Corporation?) shall be held at such place either within or without the State of Delaware as the Board of Directors may determine. Section 2. Annual and Special Meetings. Annual meetings of stockholders shall be held, at a date, time and pla |
|
| January 26, 2016 |
MDAS / MedAssets, Inc. / BlackRock Inc. Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 3) MEDASSETS INC. - (Name of Issuer) Common Stock - (Title of Class of Securities) 584045108 - (CUSIP Number) December 31, 2015 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is fil |
|
| January 14, 2016 |
Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders 8-K 1 f8k011416.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 14, 2016 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction (Commis |
|
| January 14, 2016 |
MedAssets’ Stockholders Approve Merger With Pamplona Capital Management EX-99.1 2 exh991.htm EXHIBIT 99.1 EXHIBIT 99.1 MedAssets’ Stockholders Approve Merger With Pamplona Capital Management ATLANTA, Jan. 14, 2016 (GLOBE NEWSWIRE) - MedAssets, Inc. (NASDAQ:MDAS) today announced that its stockholders approved the previously disclosed Agreement and Plan of Merger (“Merger Agreement”) with Pamplona Capital Management LLP at its special meeting of stockholders held today. |
|
| January 8, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 1)1 MedAssets, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 584045108 (CUSIP Number) JEFFREY C. SMITH STARB |
|
| December 10, 2015 |
MDAS / MedAssets, Inc. / FMR LLC / Fidelity Passive Investment SCHEDULE 13G Amendment No. 3 MEDASSETS INC COMMON STOCK Cusip #584045108 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #584045108 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 2,409,645 Item 6: 0 Item 7: 2,467,861 Item 8: 0 Item 9: 2,467,861 Item 11: 4.162% |
|
| December 9, 2015 |
MedAssets and Pamplona Announce Early Termination of HSR Act Waiting Period in Proposed Transaction MedAssets and Pamplona Announce Early Termination of HSR Act Waiting Period in Proposed Transaction EXHIBIT 99. |
|
| December 9, 2015 |
DEFA14A 1 gff8k120915.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 9, 2015 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or Other Jurisdiction of |
|
| December 9, 2015 |
Financial Statements and Exhibits, Other Events 8-K 1 gff8k120915.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 9, 2015 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or Other Jurisdiction of Inco |
|
| December 9, 2015 |
MedAssets and Pamplona Announce Early Termination of HSR Act Waiting Period in Proposed Transaction EX-99.1 2 exh991.htm EXHIBIT 99.1 EXHIBIT 99.1 MedAssets and Pamplona Announce Early Termination of HSR Act Waiting Period in Proposed Transaction ATLANTA, Dec. 9, 2015 (GLOBE NEWSWIRE) - MedAssets, Inc. (NASDAQ:MDAS) and Pamplona Capital Management LLP today announced that, on December 8, 2015, the U.S. Federal Trade Commission granted early termination of the waiting period under the Hart-Scott- |
|
| December 4, 2015 |
DEFM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| November 23, 2015 |
PREM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| November 20, 2015 |
Form 11-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 6, 2015 |
MedAssets Form 10-Q (Quarterly Report) 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-33881 MEDASSETS, INC. |
|
| November 6, 2015 |
MedAssets Services, LLC Senior Executive Change in Control Severance Plan EX-10.1 Exhibit 10.1 MedAssets Services, LLC Senior Executive Change in Control Severance Plan ARTICLE 1. Plan Purpose and Effective Date 1.1 Purpose. The purpose of the MedAssets Services, LLC Senior Executive Change in Control Severance Plan (the ?Plan?) is to assure MedAssets Services, LLC and its Affiliates (collectively, the ?Company?) of the continued dedication, loyalty, and service of, and |
|
| November 6, 2015 |
MedAssets 10-Q (Quarterly Report) 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-33881 MEDASSETS, INC. |
|
| November 4, 2015 |
Frequently Asked Questions (“FAQs”) MedAssets Agrees to be Acquired by Pamplona Capital Management EX-99.1 2 d43699dex991.htm EX-99.1 Exhibit 99.1 Frequently Asked Questions (“FAQs”) MedAssets Agrees to be Acquired by Pamplona Capital Management Please refer all media or investment community inquiries to Robert Borchert, 678.248.8194, [email protected] Acquisition Details Q: What is the total acquisition value, how is it structured, and when do you expect the deal to close? Pamplona Capit |
|
| November 4, 2015 |
Financial Statements and Exhibits, Other Events 8-K 1 d43699d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 4, 2015 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or Other Jurisdiction of Incorporati |
|
| November 4, 2015 |
Frequently Asked Questions (“FAQs”) MedAssets Agrees to be Acquired by Pamplona Capital Management EX-99.1 Exhibit 99.1 Frequently Asked Questions (?FAQs?) MedAssets Agrees to be Acquired by Pamplona Capital Management Please refer all media or investment community inquiries to Robert Borchert, 678.248.8194, [email protected] Acquisition Details Q: What is the total acquisition value, how is it structured, and when do you expect the deal to close? Pamplona Capital Management will acquire |
|
| November 4, 2015 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 4, 2015 MedAssets, Inc. |
|
| November 2, 2015 |
MedAssets 8-K (Current Report/Significant Event) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 2, 2015 MedAssets, Inc. |
|
| November 2, 2015 |
MedAssets Reports Third Quarter and Nine-Month 2015 Financial Results EXHIBIT 99.1 MedAssets Reports Third Quarter and Nine-Month 2015 Financial Results ATLANTA, Nov. 2, 2015 (GLOBE NEWSWIRE) - MedAssets, Inc. (NASDAQ:MDAS) today announced results for its third quarter and nine-month period ended September 30, 2015, which are summarized below. Three-Month Period (In millions, except per share) 3Q'15 3Q'14 % Change Net Revenue: Spend and Clinical Resource Mgmt. (SCM) |
|
| November 2, 2015 |
EX-2.1 2 d92242dex21.htm EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER among MAGNITUDE PARENT HOLDINGS, LLC MAGNITUDE ACQUISITION CORP. and MEDASSETS, INC. Dated as of November 1, 2015 TABLE OF CONTENTS Page ARTICLE I. THE MERGER 1 Section 1.1. The Merger 1 Section 1.2. Closing 2 Section 1.3. Effective Time 2 Section 1.4. Effects of the Merger 2 Section 1.5. Certificate of Incorporation and By-l |
|
| November 2, 2015 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 2, 2015 MedAssets, Inc. |
|
| November 2, 2015 |
AMENDMENT TO THE BYLAWS OF MEDASSETS, INC. (As amended effective November 1, 2015) EX-3.1 Exhibit 3.1 AMENDMENT TO THE BYLAWS OF MEDASSETS, INC. (As amended effective November 1, 2015) A new Section 9 is hereby appended to Article VIII of the Bylaws of MedAssets, Inc., a Delaware corporation, as follows: Section 9. Forum for Adjudication of Disputes. Unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for (i) any deri |
|
| November 2, 2015 |
EX-99.1 Exhibit 99.1 To all of my colleagues at MedAssets, I write to you today to announce that we have reached an agreement for MedAssets to be acquired by Pamplona Capital Management, a private equity firm based in London and New York. The agreement calls for Pamplona to purchase MedAssets for $2.7 billion or $31.35 per share, and we expect the acquisition to be completed in the first quarter o |
|
| November 2, 2015 |
EX-99.1 Exhibit 99.1 To all of my colleagues at MedAssets, I write to you today to announce that we have reached an agreement for MedAssets to be acquired by Pamplona Capital Management, a private equity firm based in London and New York. The agreement calls for Pamplona to purchase MedAssets for $2.7 billion or $31.35 per share, and we expect the acquisition to be completed in the first quarter o |
|
| November 2, 2015 |
8-K 1 d92242d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 1, 2015 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or Other Jurisdiction of Incorp |
|
| November 2, 2015 |
EX-2.1 2 d92242dex21.htm EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER among MAGNITUDE PARENT HOLDINGS, LLC MAGNITUDE ACQUISITION CORP. and MEDASSETS, INC. Dated as of November 1, 2015 TABLE OF CONTENTS Page ARTICLE I. THE MERGER 1 Section 1.1. The Merger 1 Section 1.2. Closing 2 Section 1.3. Effective Time 2 Section 1.4. Effects of the Merger 2 Section 1.5. Certificate of Incorporation and By-l |
|
| November 2, 2015 |
EX-2.1 2 d92242dex21.htm EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER among MAGNITUDE PARENT HOLDINGS, LLC MAGNITUDE ACQUISITION CORP. and MEDASSETS, INC. Dated as of November 1, 2015 TABLE OF CONTENTS Page ARTICLE I. THE MERGER 1 Section 1.1. The Merger 1 Section 1.2. Closing 2 Section 1.3. Effective Time 2 Section 1.4. Effects of the Merger 2 Section 1.5. Certificate of Incorporation and By-l |
|
| November 2, 2015 |
MedAssets to be Acquired by Pamplona Capital Management for $2.7 Billion EX-99.1 4 d92242dex991.htm EX-99.1 Exhibit 99.1 MedAssets to be Acquired by Pamplona Capital Management for $2.7 Billion ATLANTA – November 2, 2015 – MedAssets, Inc. (NASDAQ: MDAS) and Pamplona Capital Management today announced that they have entered into a definitive agreement whereby Pamplona will acquire MedAssets for $31.35 per share in cash. The purchase price represents a 44.5% premium to t |
|
| November 2, 2015 |
DEFA14A 1 d92242d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 1, 2015 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or Other Jurisdiction of In |
|
| November 2, 2015 |
MedAssets Form 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 1, 2015 MedAssets, Inc. |
|
| November 2, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2015 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File N |
|
| November 2, 2015 |
MedAssets to be Acquired by Pamplona Capital Management for $2.7 Billion EX-99.1 4 d92242dex991.htm EX-99.1 Exhibit 99.1 MedAssets to be Acquired by Pamplona Capital Management for $2.7 Billion ATLANTA – November 2, 2015 – MedAssets, Inc. (NASDAQ: MDAS) and Pamplona Capital Management today announced that they have entered into a definitive agreement whereby Pamplona will acquire MedAssets for $31.35 per share in cash. The purchase price represents a 44.5% premium to t |
|
| November 2, 2015 |
AMENDMENT TO THE BYLAWS OF MEDASSETS, INC. (As amended effective November 1, 2015) EX-3.1 Exhibit 3.1 AMENDMENT TO THE BYLAWS OF MEDASSETS, INC. (As amended effective November 1, 2015) A new Section 9 is hereby appended to Article VIII of the Bylaws of MedAssets, Inc., a Delaware corporation, as follows: Section 9. Forum for Adjudication of Disputes. Unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for (i) any deri |
|
| October 13, 2015 |
MDAS / MedAssets, Inc. / EAGLE ASSET MANAGEMENT INC Passive Investment October 8, 2015 Securities and Exchange Commission 100 F Street NE Washington, DC 20549 RE: Schedule 13G MedAssets Inc. |
|
| September 30, 2015 |
MedAssets FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 28, 2015 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File |
|
| September 8, 2015 |
Fred Hessler Joins MedAssets Board of Directors EX-99 2 newsrelease.htm PRESS RELEASE EXHIBIT 99.1 Fred Hessler Joins MedAssets Board of Directors Appointment to Create Independent Majority of Board ATLANTA, Sept. 8, 2015 (GLOBE NEWSWIRE) - MedAssets, Inc. (NASDAQ:MDAS) is pleased to announce that Frederick A. Hessler has been appointed as an independent member of the company's board of directors. He will serve as a member of the audit committe |
|
| September 8, 2015 |
8-K 1 document.htm FORM 8-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 8, 2015 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other juri |
|
| August 24, 2015 |
MDAS / MedAssets, Inc. / FMR LLC / Fidelity Passive Investment SCHEDULE 13G Amendment No. 2 MEDASSETS INC COMMON STOCK Cusip #584045108 As of January 30, 2015* Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *This Schedule 13G reflects holdings as of January 30, 2015 Cusip #584045108 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5 |
|
| August 4, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-33881 MEDASSETS, INC. |
|
| August 4, 2015 |
MedAssets FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 4, 2015 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File Num |
|
| August 3, 2015 |
Exhibit 99.2 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $0.01 par value, of MedAssets, Inc. This Joint Filing Agreement shall be fi |
|
| August 3, 2015 |
begin 644 ex991to13d0629716207222015.pdf M)5!$1BTQ+C4-)>+CS],-"C8X(# @;V)J#3P\+TQI;F5A#" X0H04BUH(D#H%8"T#$:1"W'4@\F5LO5FEE=UTO179E;G0O5FEE=SX^/#PO0V%T96=O%LP(# @-C$R(#'1=+UA/8FIE8W0\/"]);67!E+T]B:E-T;3X^ MR4JPR6,?#IJ=VYZ964W0("%DH%P&P8!2N8*K*S%KU['JP.69N"X.WV*YV>+) M:7$3CY:)5DXL=L6FA4R+15UU\WG]]WEB78!))CUH*24H*?T+6Q^*?12K/R?B6^=\6N7,^JS2Z"%,LN[G] \&+U?H@<1MUN.^7N9],P;.7"]+F=>+*,? MR>/O4/.8>Y+]F;I |
|
| August 3, 2015 |
Exhibit 99.3 POWER OF ATTORNEY The undersigned hereby appoints Jeffrey C. Smith, Mark R. Mitchell, Peter A. Feld and Kenneth R. Marlin, or any of them, his true and lawful attorney-in fact and agent to execute and file with the Securities and Exchange Commission any Schedule 13D, Schedule 13G, Form 3, Form 4, Form 5, any settlement agreement, any amendments to any of the foregoing and any related |
|
| August 3, 2015 |
MDAS / MedAssets, Inc. / Starboard Value LP - THE SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. )1 MedAssets, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 584045108 (CUSIP Number) JEFFREY C. SMITH STARBO |
|
| July 29, 2015 |
MedAssets FORM 8-K FILING DOCUMENT (Current Report/Significant Event) Form 8-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 29, 2015 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Comm |
|
| July 29, 2015 |
MedAssets Reports Second Quarter and Six-Month 2015 Financial Results MedAssets Reports Second Quarter and Six-Month 2015 Financial Results EXHIBIT 99.1 MedAssets Reports Second Quarter and Six-Month 2015 Financial Results ATLANTA, July 29, 2015 (GLOBE NEWSWIRE) - MedAssets, Inc. (NASDAQ:MDAS) today announced results for its second quarter and six-month period ended June 30, 2015, which are summarized below. Three-Month Period (In millions, except per share) 2Q'15 2 |
|
| July 2, 2015 |
MDAS / MedAssets, Inc. / Litespeed Management, L.L.C. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| June 22, 2015 |
Kevin M. Twomey Joins MedAssets Board of Directors EX-99.1 Exhibit 99.1 Kevin M. Twomey Joins MedAssets Board of Directors ATLANTA ? June 22, 2015 ? MedAssets, Inc. (NASDAQ: MDAS) is pleased to announce that Kevin Twomey has joined the company?s board of directors, and will also serve as an independent member of the compensation committee as well as the governance and nominating committee. ?Kevin has had a distinguished career as a senior executiv |
|
| June 22, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 22, 2015 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission F |
|
| June 15, 2015 |
MedAssets FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 11, 2015 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission |
|
| May 4, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-33881 MEDASSETS, INC. |
|
| April 29, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Form 8-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 29, 2015 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Comm |
|
| April 29, 2015 |
MedAssets Reports First Quarter 2015 Financial Results MedAssets Reports First Quarter 2015 Financial Results EXHIBIT 99.1 MedAssets Reports First Quarter 2015 Financial Results ATLANTA, April 29, 2015 (GLOBE NEWSWIRE) - MedAssets, Inc. (Nasdaq:MDAS) today announced results for its first quarter ended March 31, 2015, which are summarized below. ($ in millions, except per share) 1Q'15 1Q'14 % Change Net Revenue: Spend and Clinical Resource Mgmt (SCM) $ |
|
| April 24, 2015 |
DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 23, 2015 |
MedAssets FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 23, 2015 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission |
|
| March 17, 2015 |
MedAssets 8-K (Current Report/Significant Event) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 17, 2015 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File |
|
| March 17, 2015 |
EX-99.1 Exhibit 99.1 Chuck Garner Promoted to Chief Strategy and Transformation Officer; Anthony Colaluca Joins MedAssets as Chief Financial Officer ATLANTA (March 17, 2015) ? MedAssets, Inc. (NASDAQ: MDAS) today announced that Charles O. Garner was promoted to serve as executive vice president and chief strategy and transformation officer. Mr. Garner will lead the company?s growth strategy, opera |
|
| March 17, 2015 |
AMENDED AND RESTATED EMPLOYMENT AGREEMENT EX-10.1 Exhibit 10.1 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this ?Agreement?) is made and entered into as of this 17th day of March 2015, by and between MedAssets, Inc., a Delaware corporation (the ?Company?), and Charles Garner (?Executive?). W I T N E S S E T H : WHEREAS, Executive is currently serving as the Chief Financial Officer of the Compa |
|
| March 17, 2015 |
EX-10.2 Exhibit 10.2 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this ?Agreement?) is made and entered into as of this 17th day of March 2015, by and between MedAssets, Inc., a Delaware corporation (the ?Company?), and Anthony Colaluca (?Executive?). W I T N E S S E T H : WHEREAS, the Company desires to employ Executive as its Executive Vice President and Chief Financial Officer and to enter i |
|
| March 2, 2015 |
Table of Contents Index to Financial Statements UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 2, 2015 |
EX-10.14 3 d825932dex1014.htm EX-10.14 Exhibit 10.14 MedAssets, Inc. MedAssets, Inc. Long-Term Performance Incentive Plan Performance Restricted Stock Unit Award Agreement Date of Grant: Performance Period: Performance Measures and Performance Goals: See Section 3 of this Agreement. Vesting Date: Earned PRSUs shall be subject to time-based vesting restrictions, which shall lapse on the date and in |
|
| March 2, 2015 |
EX-10.13 2 d825932dex1013.htm EX-10.13 Exhibit 10.13 MedAssets, Inc. MedAssets, Inc. Long-Term Performance Incentive Plan Restricted Stock Unit Award Agreement Date of Grant: Vesting: RSUs shall be subject to time-based vesting restrictions THIS AGREEMENT, effective as of the Date of Grant, represents the grant of RSUs by MedAssets, Inc., a Delaware corporation (the “Company”), to the Participant |
|
| March 2, 2015 |
EX-21 4 d825932dex21.htm EX-21 Exhibit 21 Subsidiaries of MedAssets, Inc. As of December 31, 2014 Subsidiary Jurisdiction of Formation KP Select, LLC Delaware MedAssets Insurance Solutions, LLC Delaware MedAssets Net Revenue Systems, LLC Delaware MedAssets Services, LLC Delaware MedAssets Performance Management Solutions, Inc. Delaware MedAssets Ventures, LLC Delaware |
|
| February 17, 2015 |
Exhibit 10.2 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of this 17th day of February 2015, by and between MedAssets, Inc., a Delaware corporation (the “Company”), and R. Halsey Wise (“Executive”). W I T N E S S E T H : WHEREAS, Executive is currently a non-employee director of the Company; and WHEREAS, the Company desires to employ Executive as it |
|
| February 17, 2015 |
MedAssets Reports Fourth Quarter and Full-Year 2014 Financial Results EXHIBIT 99.1 MedAssets Reports Fourth Quarter and Full-Year 2014 Financial Results ATLANTA, Feb. 17, 2015 (GLOBE NEWSWIRE) - MedAssets, Inc. (Nasdaq:MDAS) today announced results for its fourth quarter and twelve-month period ended December 31, 2014. Fourth Quarter (In millions, except per share) 4Q'14 4Q'13 % Change Net Revenue: Spend and Clinical Resource Mgmt (SCM) $125.3 $106.4 17.7% Revenue C |
|
| February 17, 2015 |
John A. Bardis to Retire; R. Halsey Wise Named Chairman and CEO of MedAssets EXHIBIT 99.1 John A. Bardis to Retire; R. Halsey Wise Named Chairman and CEO of MedAssets ATLANTA, Feb. 17, 2015 (GLOBE NEWSWIRE) - MedAssets, Inc. (Nasdaq:MDAS) today announced that R. Halsey Wise has been appointed chairman and chief executive officer of the company, effective immediately. Mr. Wise joined MedAssets board of directors in March 2014. Mr. Wise succeeds John A. Bardis, who is retiri |
|
| February 17, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 17, 2015 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File |
|
| February 17, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 17, 2015 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File N |
|
| February 17, 2015 |
MedAssets Announces Extension of Share Repurchase Plan and Increase to $100 Million EXHIBIT 99.1 MedAssets Announces Extension of Share Repurchase Plan and Increase to $100 Million ATLANTA, Feb. 17, 2015 (GLOBE NEWSWIRE) - MedAssets, Inc. (Nasdaq:MDAS) today announced that its board of directors authorized an extension of the existing share repurchase program to February 29, 2016 and increased the amount available for the repurchase of shares to $100 million, subject to certain c |
|
| February 17, 2015 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 17, 2015 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File N |
|
| February 17, 2015 |
TRANSITION AND CONSULTING AGREEMENT Exhibit 10.1 TRANSITION AND CONSULTING AGREEMENT THIS TRANSITION AND CONSULTING AGREEMENT (this “Agreement”), effective as of February 17, 2015 (the “Effective Date”), is made by and between MedAssets, Inc., a Delaware corporation (the “Company”), and John A. Bardis (“Consultant”). R E C I T A L S: WHEREAS, Consultant currently serves as the Chairman and Chief Executive Officer of the Company; WHE |
|
| February 13, 2015 |
MDAS / MedAssets, Inc. / FMR LLC / Fidelity Passive Investment SCHEDULE 13G Amendment No. 1 MEDASSETS INC COMMON STOCK Cusip #584045108 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #584045108 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 259,009 Item 6: 0 Item 7: 5,127,949 Item 8: 0 Item 9: 5,127,949 Item 11: 8.517% It |
|
| February 13, 2015 |
SC 13G/A 1 medassets13g12312014.htm AMENDMENT NO. 1 TO SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Under the Securities Exchange Act of 1934 (Amendment No. 1)* Medassets Inc (Name of Issuer) Common Stock (Title of Class of Securities) 584045108 (CUSIP Number) December 31, 2014 (Date of Event which Requires Filing of this Statemen |
|
| February 11, 2015 |
MDAS / MedAssets, Inc. / VANGUARD GROUP INC Passive Investment medassetsinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1 )* Name of issuer: MedAssets Inc Title of Class of Securities: Common Stock CUSIP Number: 584045108 Date of Event Which Requires Filing of this Statement: December 31, 2014 Check the appropriate box to design |
|
| February 5, 2015 |
MDAS / MedAssets, Inc. / BROWN CAPITAL MANAGEMENT LLC Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 5)* MedAssets Inc. (Name of Issuer) Common Stock, Par Value $0.01 (Title of Class of Securities) 584045108 (CUSIP Number) December 31, 2014 (Date of Event Wh |
|
| January 22, 2015 |
MDAS / MedAssets, Inc. / BlackRock Inc. Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) MEDASSETS INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 584045108 - (CUSIP Number) December 31, 2014 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is file |
|
| January 13, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 d850716d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 13, 2015 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of inc |
|
| January 13, 2015 |
EX-99.1 Performance Improvement for Healthcare Providers J. P. Morgan Healthcare Conference January 13, 2015 Exhibit 99.1 Confidential. Property of MedAssets. MedAssets® is a registered trademark of MedAssets, Inc. © 2013 MedAssets, Inc. All rights reserved. 2 Safe Harbor/Non-GAAP Disclosures Safe Harbor Statement This presentation contains forward-looking statements within the meaning of the Secu |
|
| January 8, 2015 |
MDAS / MedAssets, Inc. / EAGLE ASSET MANAGEMENT INC - MEDASSETS INC. Passive Investment January 8, 2015 Securities and Exchange Commission 100 F Street NE Washington, DC 20549 RE: Amended Schedule 13G MedAssets Inc. |
|
| January 6, 2015 |
EX-10.1 2 d845470dex101.htm EX-10.1 Exhibit 10.1 MedAssets Services, LLC Separation and Release Agreement PLEASE READ CAREFULLY BEFORE SIGNING THIS AGREEMENT INCLUDES A RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS This document sets forth the terms of the agreement between you and the Company relating to your separation from employment (the “Agreement”). This Agreement is between you on the one hand, a |
|
| January 6, 2015 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 31, 2014 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission F |
|
| December 10, 2014 |
8-K 1 d835318d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 4, 2014 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorpor |
|
| December 10, 2014 |
MedAssets COO Mike Nolte Promoted to President and Appointed to Company’s Board of Directors EX-99.1 2 d835318dex991.htm EX-99.1 Exhibit 99.1 MedAssets COO Mike Nolte Promoted to President and Appointed to Company’s Board of Directors ATLANTA—December 10, 2014—MedAssets (NASDAQ: MDAS) today announced that Mike Nolte, who currently serves as executive vice president and chief operating officer (COO), was promoted to president and COO and has been appointed to the company’s board of directo |
|
| November 17, 2014 |
MDAS / MedAssets, Inc. 11-K - - FORM 11-K Form 11-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 7, 2014 |
MedAssets Services, LLC Senior Executive Change in Control Severance Plan EX-10.2 3 d789484dex102.htm EX-10.2 Exhibit 10.2 MedAssets Services, LLC Senior Executive Change in Control Severance Plan ARTICLE 1. Plan Purpose and Effective Date 1.1 Purpose. The purpose of the MedAssets Services, LLC Senior Executive Change in Control Severance Plan (the “Plan”) is to assure MedAssets Services, LLC and its Affiliates (collectively, the “Company”) of the continued dedication, |
|
| November 7, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-33881 MEDASSETS, INC. |
|
| November 7, 2014 |
MEDASSETS, INC. EMPLOYMENT AGREEMENT EX-10.1 2 d789484dex101.htm EX-10.1 Exhibit 10.1 MEDASSETS, INC. AMENDMENT TO EMPLOYMENT AGREEMENT This Amendment (“Amendment”) to the Agreement (defined below) is entered into as of 14 July 2014, by and among MedAssets, Inc. (the “Company”), and Mike Nolte (“Employee”). WHEREAS, the Company and Employee are parties to that certain employment agreement dated as of March 5, 2012 and amended as of D |
|
| October 29, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 29, 2014 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| October 29, 2014 |
MedAssets Reports Third Quarter and Nine-Month 2014 Financial Results EXHIBIT 99.1 MedAssets Reports Third Quarter and Nine-Month 2014 Financial Results ATLANTA, Oct. 29, 2014 (GLOBE NEWSWIRE) - MedAssets, Inc. (Nasdaq:MDAS) today announced results for its third quarter and nine-month period ended September 30, 2014. Third Quarter (In millions, except per share) 3Q'14 3Q'13 % Change Net Revenue: Spend and Clinical Resource Mgmt (SCM) $105.8 $103.2 2.5% Revenue Cycle |
|
| September 22, 2014 |
Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 22, 2014 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commis |
|
| September 22, 2014 |
MedAssets Completes Acquisition of Sg2 EX-99.1 Exhibit 99.1 MedAssets Completes Acquisition of Sg2 ATLANTA – September 22, 2014 — MedAssets (NASDAQ: MDAS) today announced that it completed its previously announced acquisition of SG-2, LLC (Sg2), a leading provider of healthcare business intelligence, market analytics and clinical consulting services. “Working with more than 1,400 hospitals and other clients across healthcare, Sg2’s exp |
|
| September 12, 2014 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 8, 2014 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commiss |
|
| September 12, 2014 |
FIRST INCREASE JOINDER TO CREDIT AGREEMENT EX-99.1 Exhibit 99.1 FIRST INCREASE JOINDER TO CREDIT AGREEMENT FIRST INCREASE JOINDER TO CREDIT AGREEMENT, dated as of September 8, 2014 (this “First Increase Joinder”), by and among MEDASSETS, INC., a Delaware corporation (the “Borrower”), each Guarantor, JPMORGAN CHASE BANK, N.A., as administrative agent (in such capacity, the “Administrative Agent”), the lenders set forth on Exhibit A attached |
|
| August 13, 2014 |
EX-2.1 Exhibit 2.1 MEMBERSHIP INTEREST PURCHASE AGREEMENT by and among MICHAEL A. SACHS, MICHAEL J. BURKE, MICHAEL A. SACHS CHARITABLE REMAINDER UNITRUST, MICHAEL J. BURKE TRUST DATED SEPTEMBER 5, 2002, SG-2 MANAGEMENT, LLC SG-2 MANAGEMENT B, LLC SG-2, LLC MICHAEL A. SACHS, AS THE SELLERS’ REPRESENTATIVE and MEDASSETS, INC. TABLE OF CONTENTS ARTICLE I THE TRANSACTION 1 Section 1.1 Purchase and Sal |
|
| August 13, 2014 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 13, 2014 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File |
|
| August 13, 2014 |
EX-99.1 Exhibit 99.1 MedAssets Signs Definitive Agreement to Acquire Sg2 Market Intelligence and Strategic Analytics Platform to Enrich MedAssets Leadership in Performance Improvement ATLANTA (August 13, 2014) – MedAssets, Inc., (NASDAQ: MDAS) today announced it signed a definitive agreement to acquire privately held SG-2, LLC (Sg2) for approximately $142 million. Based in Skokie, Ill., Sg2 is a l |
|
| August 11, 2014 |
MDAS / MedAssets, Inc. / FMR LLC / Fidelity Passive Investment SCHEDULE 13G Amendment No. 0 MEDASSETS INC COMMON STOCK Cusip #584045108 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #584045108 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 188,401 Item 6: 0 Item 7: 6,854,770 Item 8: 0 Item 9: 6,854,770 Item 11: 11.240% I |
|
| August 4, 2014 |
MEDASSETS, INC. EMPLOYMENT AGREEMENT EX-10.1 2 d729667dex101.htm EX-10.1 Exhibit 10.1 MEDASSETS, INC. AMENDMENT TO EMPLOYMENT AGREEMENT This Amendment (“Amendment”) to the Agreement (defined below) is entered into as of 26 June 2014, by and among MedAssets, Inc. (the “Company”), and Rand Ballard (“Employee”). WHEREAS, the Company and Employee are parties to that certain employment agreement dated as of August 22, 2007 as amended and |
|
| August 4, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q 10-Q 1 d729667d10q.htm FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commis |
|
| July 30, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 30, 2014 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| July 30, 2014 |
MedAssets Reports Second Quarter and Six-Month 2014 Financial EXHIBIT 99.1 MedAssets Reports Second Quarter and Six-Month 2014 Financial ATLANTA, July 30, 2014 (GLOBE NEWSWIRE) - MedAssets, Inc. (Nasdaq:MDAS) today announced results for its second quarter and six-month period ended June 30, 2014. Second Quarter (In millions, except per share) 2Q'14 2Q'13 % Change Net Revenue: Spend and Clinical Resource Mgmt (SCM) $ 105.9 $ 105.3 0.6% Revenue Cycle Managemen |
|
| June 13, 2014 |
Submission of Matters to a Vote of Security Holders - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 12, 2014 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission |
|
| May 20, 2014 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 15, 2014 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File N |
|
| May 7, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-33881 MEDASSETS, INC. |
|
| April 30, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 30, 2014 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| April 30, 2014 |
DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 30, 2014 |
MedAssets Reports First Quarter 2014 Financial Results EXHIBIT 99.1 MedAssets Reports First Quarter 2014 Financial Results ATLANTA, April 30, 2014 (GLOBE NEWSWIRE) - MedAssets, Inc. (Nasdaq:MDAS) today announced results for its first quarter ended March 31, 2014, which are summarized below. ($ in millions, except per share) 1Q'14 1Q'13 % Change Net Revenue: Spend and Clinical Resource Mgmt (SCM) $108.6 $109.5 (0.8)% Revenue Cycle Management (RCM) 62.3 |
|
| April 30, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 30, 2014 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| March 13, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 7, 2014 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| March 13, 2014 |
R. Halsey Wise Joins MedAssets Board of Directors EXHIBIT 99.1 R. Halsey Wise Joins MedAssets Board of Directors ATLANTA, March 13, 2014 (GLOBE NEWSWIRE) - MedAssets, Inc. (Nasdaq:MDAS) is pleased to announce that R. Halsey Wise has joined the company's board of directors. Mr. Wise is the founder and chief executive officer of Lime Barrel Advisors, a private investment firm. In his new position with MedAssets, Mr. Wise will also be a member of th |
|
| March 3, 2014 |
EX-21 7 d630696dex21.htm EX-21 Exhibit 21 Subsidiaries of MedAssets, Inc. As of December 31, 2013 Subsidiary Jurisdiction of Formation KP Select, LLC Delaware MedAssets Insurance Solutions, LLC Delaware MedAssets Net Revenue Systems, LLC Delaware MedAssets Services, LLC Delaware MedAssets Performance Management Solutions, Inc. Delaware MedAssets Ventures, LLC Delaware |
|
| March 3, 2014 |
Exhibit 10.15 EMPLOYMENT AGREEMENT This AMENDED AND RESTATED EMPLOYMENT AGREEMENT is made and entered into as of this 22nd day of August, 2007, and amended as of this 2nd day of May 2011, by and between MedAssets, Inc., a Delaware corporation (the ?Company?), and Jonathan H. Glenn (?Employee?). W I T N E S S E T H: WHEREAS, the Company desires to employ Employee and to enter into an agreement embo |
|
| March 3, 2014 |
Senior Executive Change in Control Severance Plan Exhibit 10.19 MedAssets Services, LLC Senior Executive Change in Control Severance Plan ARTICLE 1. Plan Purpose and Effective Date 1.1 Purpose. The purpose of the MedAssets Services, LLC Senior Executive Change in Control Severance Plan (the ?Plan?) is to assure MedAssets Services, LLC and its Affiliates (collectively, the ?Company?) of the continued dedication, loyalty, and service of, and the av |
|
| March 3, 2014 |
MEDASSETS, INC. EMPLOYMENT AGREEMENT Exhibit 10.20 MEDASSETS, INC. AMENDMENT TO EMPLOYMENT AGREEMENT This Amendment (?Amendment?) to the Agreement (defined below) is entered into as of December 11, 2013, by and among MedAssets, Inc. (the ?Company?), and John Bardis (?Employee?). WHEREAS, the Company and Employee are parties to that certain employment agreement dated as of August 21, 2007 as amended and restated on May 2, 2011 which g |
|
| March 3, 2014 |
MEDASSETS, INC. EMPLOYMENT AGREEMENT Exhibit 10.21 MEDASSETS, INC. AMENDMENT TO EMPLOYMENT AGREEMENT This Amendment (?Amendment?) to the Agreement (defined below) is entered into as of December 11, 2013, by and among MedAssets, Inc. (the ?Company?), and Rand Ballard (?Employee?). WHEREAS, the Company and Employee are parties to that certain employment agreement dated as of August 22, 2007 as amended and restated on May 2, 2011 which |
|
| March 3, 2014 |
10-K Table of Contents Index to Financial Statements UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 3, 2014 |
MEDASSETS, INC. EMPLOYMENT AGREEMENT Exhibit 10.22 MEDASSETS, INC. AMENDMENT TO EMPLOYMENT AGREEMENT This Amendment (?Amendment?) to the Agreement (defined below) is entered into as of December 11, 2013, by and among MedAssets, Inc. (the ?Company?), and Mike Nolte (?Employee?). WHEREAS, the Company and Employee are parties to that certain employment agreement dated as of March 5, 2012 which governs Employee?s employment with the Comp |
|
| February 26, 2014 |
MedAssets Reports Fourth Quarter and Full-Year 2013 Financial Results EXHIBIT 99.1 MedAssets Reports Fourth Quarter and Full-Year 2013 Financial Results Board of Directors Authorizes Share Repurchase Plan ATLANTA, Feb. 26, 2014 (GLOBE NEWSWIRE) - MedAssets, Inc. (Nasdaq:MDAS) today announced results for its fourth quarter and twelve-month period ended December 31, 2013. Fourth Quarter ($ in millions, except per share) 4Q'13 4Q'12 % Change Net Revenue: Spend and Clin |
|
| February 26, 2014 |
MedAssets Announces Share Repurchase Plan EXHIBIT 99.1 MedAssets Announces Share Repurchase Plan ATLANTA, Feb. 26, 2014 (GLOBE NEWSWIRE) - MedAssets, Inc. (Nasdaq:MDAS) today announced that its Board of Directors has authorized the repurchase of up to $75 million of the company's common stock over the next twelve months. The share repurchase program is intended to be implemented through purchases made from time to time using a variety of |
|
| February 26, 2014 |
Financial Statements and Exhibits, Other Events - FORM 8-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 26, 2014 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File N |
|
| February 26, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 26, 2014 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File N |
|
| February 13, 2014 |
MDAS / MedAssets, Inc. / BROWN CAPITAL MANAGEMENT LLC Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 4)* MedAssets Inc. (Name of Issuer) Common Stock, Par Value $0.01 (Title of Class of Securities) 584045108 (CUSIP Number) December 31, 2013 (Date of Event Wh |
|
| February 13, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Under the Securities Exchange Act of 1934 Medassets Inc (Name of Issuer) Common Stock (Title of Class of Securities) 584045108 (CUSIP Number) December 31, 2013 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is f |
|
| February 11, 2014 |
MDAS / MedAssets, Inc. / VANGUARD GROUP INC Passive Investment medassets.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 0 )* Name of issuer: MedAssets Inc Title of Class of Securities: Common Stock CUSIP Number: 584045108 Date of Event Which Requires Filing of this Statement: December 31, 2013 Check the appropriate box to designate |
|
| January 30, 2014 |
MDAS / MedAssets, Inc. / BlackRock Inc. Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) MEDASSETS INC. - (Name of Issuer) Common Stock - (Title of Class of Securities) 584045108 - (CUSIP Number) December 31, 2013 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is fil |
|
| January 13, 2014 |
MDAS / MedAssets, Inc. / EAGLE ASSET MANAGEMENT INC Passive Investment SC 13G/A 1 mdas4.txt January 13, 2014 Office of the Corporate Secretary MedAssets, Inc. 100 North Point Center East Suite 200 RE: Amended Schedule 13G MedAssets, Inc. As of December 31, 2013 Gentlemen: In accordance with Section 13(d)(5) of the Securities Exchange Act of 1934, attached please find a copy of Schedule 13G for the above named company showing a change in beneficial ownership as of Dec |
|
| November 15, 2013 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended August 31, 2013 or ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file 001-33881 number A. Full title of the P |
|
| November 7, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-33881 MEDASSETS, INC. |
|
| October 30, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a50740552.htm MEDASSETS, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 30, 2013 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdict |
|
| October 30, 2013 |
MedAssets Reports Third Quarter and Nine-Month 2013 Financial Results Exhibit 99.1 MedAssets Reports Third Quarter and Nine-Month 2013 Financial Results ATLANTA-(BUSINESS WIRE)-October 30, 2013-MedAssets, Inc. (NASDAQ: MDAS) today announced results for its third quarter and nine-month periods ended September 30, 2013. Third quarter results are summarized in the table below: ($ in millions, except per share) 3Q’13 3Q’12 % Change Net Revenue: Spend and Clinical Resour |
|
| October 3, 2013 |
FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 30, 2013 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commis |
|
| October 2, 2013 |
S-8 1 d594923ds8.htm FORM S-8 As filed with the Securities and Exchange Commission on October 2, 2013 Registration No. 333-[ ] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDASSETS, INC. (Exact name of registrant as specified in its charter) Delaware 51-0391128 (State or other jurisdiction of incorporation |
|
| August 2, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q 10-Q 1 d541478d10q.htm FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commis |
|
| August 2, 2013 |
MedAssets Services, LLC Senior Executive Change in Control Severance Plan Exhibit 10.1 MedAssets Services, LLC Senior Executive Change in Control Severance Plan ARTICLE 1. Plan Purpose and Effective Date 1.1 Purpose. The purpose of the MedAssets Services, LLC Senior Executive Change in Control Severance Plan (the ?Plan?) is to assure MedAssets Services, LLC and its Affiliates (collectively, the ?Company?) of the continued dedication, loyalty, and service of, and the ava |
|
| July 31, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 31, 2013 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| July 31, 2013 |
MedAssets Reports Second Quarter and Six-Month 2013 Financial Results Exhibit 99.1 MedAssets Reports Second Quarter and Six-Month 2013 Financial Results ATLANTA-(BUSINESS WIRE)-July 31, 2013-MedAssets, Inc. (NASDAQ: MDAS) today announced results for its second quarter and six-month periods ended June 30, 2013. Second quarter results are summarized in the table below: ($ in millions, except per share) 2Q’13 2Q’12 % Change Net Revenue: Spend and Clinical Resource Mgmt |
|
| June 14, 2013 |
Submission of Matters to a Vote of Security Holders - FORM 8-K FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 13, 2013 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission |
|
| May 6, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-33881 MEDASSETS, INC. |
|
| May 1, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a50622898.htm MEDASSETS, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 1, 2013 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction o |
|
| May 1, 2013 |
MedAssets Reports First Quarter 2013 Financial Results EX-99.1 2 a50622898ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 MedAssets Reports First Quarter 2013 Financial Results ATLANTA-(BUSINESS WIRE)-May 1, 2013-MedAssets, Inc. (NASDAQ: MDAS) today announced results for its first quarter ended March 31, 2013. First quarter results are summarized in the table below: ($ in millions, except per share) 1Q’13 1Q’12 % Change Net Revenue: Spend and Clinical Resource M |
|
| April 29, 2013 |
DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 2, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 2, 2013 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| April 2, 2013 |
Xerox CIO Carol Zierhoffer Joins MedAssets Board of Directors EX-99.1 2 a50600809ex991.htm EXHIBIT 99.1 Exhibit 99.1 Xerox CIO Carol Zierhoffer Joins MedAssets Board of Directors ATLANTA-(BUSINESS WIRE)-April 2, 2013-MedAssets, Inc. (NASDAQ: MDAS) is pleased to announce that Carol J. Zierhoffer has joined the company’s board of directors. Ms. Zierhoffer is vice president and global chief information officer (CIO) for Xerox Corporation. In her new position wi |
|
| February 27, 2013 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Fiscal Year Ended December 31, 2012 Commission File No. 001-33881 MEDASSETS, INC. (Exact Name Of Registrant As Specified In Its Charter) DELAWARE 51-0391128 (State or Other Jurisdiction of Incorporation or O |
|
| February 27, 2013 |
Exhibit 21 Subsidiaries of MedAssets, Inc. As of December 31, 2012 Subsidiary Jurisdiction of Formation Aspen Healthcare Metrics LLC Delaware Broadlane NY, Inc. Delaware Dominic & Irvine, LLC Delaware Health Equipment Logistics and Planning, Inc. Delaware Healthcare Performance Partners, Inc. Delaware KP Select, Inc. Delaware MedAssets Analytical Systems, LLC Delaware MedAssets Insurance Solutions |
|
| February 20, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 20, 2013 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File |
|
| February 20, 2013 |
MDAS / MedAssets, Inc. / EAGLE ASSET MANAGEMENT INC Passive Investment February 19, 2013 Office of the Corporate Secretary MedAssets, Inc. 100 North Point Center East Suite 200 RE: Amended 13G MedAssets, Inc. As of January 31, 2013 Gentlemen: In accordance with Section 13(d)(5) of the Securities Exchange Act of 1934, attached please find a copy of Schedule 13G for the above named company showing a change in beneficial ownership of10% or more as ofJanuary31,2013 filed |
|
| February 20, 2013 |
MedAssets Reports Fourth Quarter and Full-Year 2012 Financial Results Exhibit 99.1 MedAssets Reports Fourth Quarter and Full-Year 2012 Financial Results ATLANTA-(BUSINESS WIRE)-February 20, 2013-MedAssets, Inc. (NASDAQ: MDAS) today announced results for its fourth quarter and full year ended December 31, 2012. Fourth quarter results are summarized in the table below: ($ in millions, except per share) 4Q-12 4Q-11 % Change Net Revenue: Spend and Clinical Resource Mgmt |
|
| February 14, 2013 |
MDAS / MedAssets, Inc. / TREMBLANT CAPITAL GROUP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 14, 2013 |
MDAS / MedAssets, Inc. / Senator Investment Group LP - MEDASSETS, INC. Passive Investment SC 13G/A 1 p13-0609sc13ga.htm MEDASSETS, INC. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* MedAssets, Inc. (Name of Issuer) Common Stock, $0.01 per share (Title of Class of Securities) 584045108 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of This Statement) Check the appropriate box t |
|
| February 14, 2013 |
MDAS / MedAssets, Inc. / BROWN CAPITAL MANAGEMENT LLC Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 3)* MedAssets Inc. (Name of Issuer) Common Stock, Par Value $0.01 (Title of Class of Securities) 584045108 (CUSIP Number) December 31, 2012 (Date of Event Wh |
|
| February 14, 2013 |
MDAS / MedAssets, Inc. / SAC Capital Advisors LP - AMENDMENT NO. 1 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* MEDASSETS, INC. (Name of Issuer) Common Stock, Par Value $0.01 Per Share (Title of Class of Securities) 584045108 (CUSIP Number) December 31, 2012 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pur |
|
| February 13, 2013 |
MDAS / MedAssets, Inc. / Claudius IV, LLC - SC 13G AMENDMENT NO. 5 Passive Investment SC 13G Amendment No. 5 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 5)* MedAssets, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 584045108 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which thi |
|
| January 30, 2013 |
MDAS / MedAssets, Inc. / BlackRock Inc. Passive Investment SC 13G 1 medassets.inc..txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: ) MEDASSETS INC. - (Name of Issuer) Common Stock - (Title of Class of Securities) 584045108 - (CUSIP Number) December 31, 2012 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| January 29, 2013 |
MDAS / MedAssets, Inc. / EAGLE ASSET MANAGEMENT INC Passive Investment January 29, 2013 Securities and Exchange Commission 450 Fifth Street NW Washington, DC 20549 RE: Amended 13G MedAssets, Inc. |
|
| December 18, 2012 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 13, 2012 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission F |
|
| December 18, 2012 |
EX-10.1 Exhibit 10.1 Execution Version $750,000,000 CREDIT AGREEMENT dated as of December 13, 2012 among MEDASSETS, INC., THE LENDERS FROM TIME TO TIME PARTY HERETO, JPMORGAN CHASE BANK, N.A., as Administrative Agent, Collateral Agent and L/C Issuer, BANK OF AMERICA, N.A., as Swing Line Lender J.P. MORGAN SECURITIES LLC, BARCLAYS BANK PLC, DEUTSCHE BANK SECURITIES INC., MERRILL LYNCH, PIERCE, FENN |
|
| November 14, 2012 |
Form 11-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 9, 2012 |
MDAS / MedAssets, Inc. / EAGLE ASSET MANAGEMENT INC Passive Investment November 9, 2012 Securities and Exchange Commission 450 Fifth Street NW Washington, DC 20549 RE: Amended 13G MedAssets, Inc. |
|
| November 5, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-33881 MEDASSETS, INC. |
|
| October 30, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 30, 2012 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File N |
|
| October 30, 2012 |
MedAssets Reports Third Quarter and Nine Month 2012 Financial Results Exhibit 99.1 MedAssets Reports Third Quarter and Nine Month 2012 Financial Results ATLANTA-(BUSINESS WIRE)-October 30, 2012-MedAssets, Inc. (NASDAQ: MDAS) today announced results for its third quarter and nine-month periods ended September 30, 2012. Third quarter results are summarized in the table below: ($ in millions, except per share) 3Q-12 3Q-11 % Change Net Revenue: Spend and Clinical Resour |
|
| August 6, 2012 |
EX-10.1 2 d356122dex101.htm EX-10.1 Exhibit 10.1 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT is made and entered into as of this 17th day of June, 2011 by and between MedAssets Services, LLC, a Delaware limited liability company (the “Company”), and Gregory A. Strobel (“Employee”). W I T N E S S E T H: WHEREAS, the Company desires to employ Employee and to enter into an agreement embodying the |
|
| August 6, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q 10-Q 1 d356122d10q.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2012 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission |
|
| August 1, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 1, 2012 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File Num |
|
| August 1, 2012 |
MedAssets Reports Second Quarter and Six Month 2012 Financial Results Exhibit 99.1 MedAssets Reports Second Quarter and Six Month 2012 Financial Results ATLANTA-(BUSINESS WIRE)-August 1, 2012-MedAssets, Inc. (NASDAQ: MDAS) today announced results for its second quarter and six-month periods ended June 30, 2012. Second quarter results are summarized in the table below: ($ in millions, except per share) 2Q-12 2Q-11 % Change Net Revenue: Spend and Clinical Resource Mgm |
|
| June 21, 2012 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 21, 2012 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 7, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2012 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-33881 MEDASSETS, INC. |
|
| May 7, 2012 |
EX-10.2 2 d323750dex102.htm EX-10.2 Exhibit 10.2 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT is made and entered into as of this 5th day of March, 2012 by and between MedAssets, Inc., a Delaware corporation (the “Company”), and Mike Nolte (“Employee”). W I T N E S S E T H : WHEREAS, the Company desires to employ Employee and to enter into an agreement embodying the terms of such employment (thi |
|
| May 2, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 2, 2012 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File Number |
|
| May 2, 2012 |
MedAssets Reports First Quarter 2012 Financial Results Exhibit 99.1 MedAssets Reports First Quarter 2012 Financial Results ATLANTA-(BUSINESS WIRE)-May 2, 2012-MedAssets, Inc. (NASDAQ: MDAS) today announced results for its first quarter ended March 31, 2012, which are summarized in the table below: ($ in millions, except per share) 1Q-12 1Q-11 % Change Net Revenue: Spend and Clinical Resource Mgmt (SCM) $ 93.3 $ 79.3 17.6 % Revenue Cycle Management (RC |
|
| April 30, 2012 |
Definitive Proxy Statement Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 24, 2012 |
FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 19, 2012 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission |
|
| April 16, 2012 |
MDAS / MedAssets, Inc. / SAC Capital Advisors LP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* MEDASSETS, INC. (Name of Issuer) Common Stock, Par Value $0.01 Per Share (Title of Class of Securities) 584045108 (CUSIP Number) April 5, 2012 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant |
|
| April 16, 2012 |
Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to this statement on Schedule 13G may be filed on behalf of each of the undersigned without the necessi |
|
| April 2, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 30, 2012 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission |
|
| March 12, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 9, 2012 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| March 12, 2012 |
MDAS / MedAssets, Inc. / Senator Investment Group LP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* MedAssets, Inc. (Name of Issuer) Common Stock, $0.01 per share (Title of Class of Securities) 584045108 (CUSIP Number) March 2, 2012 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| March 12, 2012 |
MedAssets Appoints Michael P. Nolte Chief Operating Officer Exhibit 99.1 MedAssets Appoints Michael P. Nolte Chief Operating Officer ATLANTA-(BUSINESS WIRE)-March 12, 2012-MedAssets, Inc. (NASDAQ: MDAS) today announced that it has appointed Michael P. Nolte as executive vice president and chief operating officer, effective immediately. In this role, Mr. Nolte is responsible for overseeing day-to-day operations, and working in close collaboration with all m |
|
| February 28, 2012 |
Exhibit 21 Subsidiaries of MedAssets, Inc. As of December 31, 2011 Subsidiary Jurisdiction of Formation Aspen Healthcare Metrics LLC Delaware Broadlane Intermediate Holdings, Inc. Delaware Broadlane NY, Inc. Delaware Dominic & Irvine, LLC Delaware Health Equipment Logistics and Planning, Inc. Delaware Healthcare Performance Partners, Inc. Delaware KP Select, Inc. Delaware MedAssets Analytical Syst |
|
| February 28, 2012 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Fiscal Year Ended December 31, 2011 Commission File No. 001-33881 MEDASSETS, INC. (Exact Name Of Registrant As Specified In Its Charter) DELAWARE 51-0391128 (State or Other Jurisdiction of Incorporation or O |
|
| February 28, 2012 |
Exhibit 18 February 27, 2012 MedAssets, Inc. Alpharetta, Georgia We have audited the consolidated balance sheets of MedAssets, Inc. (the ?Company?) as of December 31, 2011 and 2010, and the related consolidated statements of operations, stockholders? equity and comprehensive income (loss), and cash flows for each of the years ended December 31, 2011 and 2010, and have reported thereon under date o |
|
| February 23, 2012 |
MedAssets Reports Fourth Quarter and Full-Year 2011 Financial Results Exhibit 99.1 MedAssets Reports Fourth Quarter and Full-Year 2011 Financial Results ATLANTA-(BUSINESS WIRE)-February 23, 2012-MedAssets, Inc. (NASDAQ: MDAS) today announced results for its fourth quarter and full-year ended December 31, 2011. Fourth quarter results are summarized in the table below: ($ in millions, except per share) 4Q-11 4Q-10 a 4Q-10 a,b Net Revenue: Recast Non-GAAP Acquisition- |
|
| February 23, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 23, 2012 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File |
|
| February 14, 2012 |
MDAS / MedAssets, Inc. / Tremblant Partners Ltd. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 14, 2012 |
MDAS / MedAssets, Inc. / TREMBLANT CAPITAL GROUP Passive Investment SC 13G 1 d126176613-g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* MedAssets, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 584045108 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
| February 13, 2012 |
MDAS / MedAssets, Inc. / PRICE T ROWE ASSOCIATES INC /MD/ - MDAS AS OF 12/31/11 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* MEDASSETS INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 584045108 (CUSIP Number) December 31, 2011 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is fi |
|
| February 13, 2012 |
MDAS / MedAssets, Inc. / Claudius IV, LLC - SCHEDULE 13G AMENDMENT NO. 4 Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. |
|
| February 13, 2012 |
MDAS / MedAssets, Inc. / PARTHENON INVESTORS L P - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* MedAssets, Inc. (Name of Issuer) Common Stock, $0.01 Par Value (Title of Class of Securities) 584045 108 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| February 13, 2012 |
MDAS / MedAssets, Inc. / BROWN CAPITAL MANAGEMENT LLC - MEDASSETS INC. Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 2)* MedAssets Inc. (Name of Issuer) Common Stock, Par Value $0.01 (Title of Class of Securities) 584045108 (CUSIP Number) December 31, 2011 (Date of Event Wh |
|
| January 30, 2012 |
MDAS / MedAssets, Inc. / BLAIR WILLIAM & CO/IL - NONE Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 01)* Medassets, Inc. (Name of Issuer) Common (Title of Class of Securities) 584045108 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is |
|
| January 25, 2012 |
MDAS / MedAssets, Inc. / EAGLE ASSET MANAGEMENT INC Passive Investment January 23, 2012 Securities and Exchange Commission 450 Fifth Street NW Washington, DC 20549 RE: Schedule 13G MedAssets, Inc. |
|
| January 23, 2012 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 19, 2012 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission Fi |
|
| January 23, 2012 |
EX-10.1 Exhibit 10.1 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT is made and entered into as of this 19th day of January 2012 by and between MedAssets Services, LLC, a Delaware corporation (the “Company”) and Allen W. Hobbs (“Employee”). W I T N E S S E T H : WHEREAS, the Company desires to employ Employee and to enter into an agreement embodying the terms of such employment (this “Agreement”) |
|
| November 18, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K 11-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 8, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-33881 MEDASSETS, INC. |
|
| November 3, 2011 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 3, 2011 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File N |
|
| November 3, 2011 |
MedAssets Reports Third Quarter and Nine-Month 2011 Financial Results Exhibit 99.1 MedAssets Reports Third Quarter and Nine-Month 2011 Financial Results ATLANTA-(BUSINESS WIRE)-November 3, 2011-MedAssets, Inc. (NASDAQ: MDAS) today announced results for its third quarter and nine months ended September 30, 2011. Third quarter results are summarized in the table below: (In millions, except per share) 3Q-11 3Q-10 a 3Q-10 a,b Net Revenue: Recast Non-GAAP Acquisition- Af |
|
| October 13, 2011 |
Table of Contents Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-175729 PROSPECTUS Offers to Exchange $325.0 million principal amount of its 8.0% senior notes due 2018, which have been registered under the Securities Act of 1933, for any and all of its outstanding 8.0% senior notes due 2018. THE EXCHANGE OFFER WILL EXPIRE AT 12:00 A.M., NEW YORK CITY TIME, ON NOVEMBER 11, 2011, UN |
|
| October 12, 2011 |
[Remainder of Page Intentionally Left Blank] CORRESP 1 filename1.htm October 12, 2011 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549-7010 Re: MedAssets, Inc. Registration Statement on Form S-4 (File No. 333-175729) Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, MedAssets, Inc. (the “Issuer”) hereby respectfully requests on behalf of itself and the gua |
|
| October 5, 2011 | ||
| October 3, 2011 |
As filed with the Securities and Exchange Commission on September 30, 2011 Table of Contents As filed with the Securities and Exchange Commission on September 30, 2011 Registration No. |
|
| September 30, 2011 |
MEDASSETS, INC. 100 North Point Center East, Suite 200 Alpharetta, Georgia 30022 MEDASSETS, INC. 100 North Point Center East, Suite 200 Alpharetta, Georgia 30022 September 30, 2011 VIA EDGAR AND FEDERAL EXPRESS Katherine Wray Staff Attorney Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-7010 Re: MedAssets, Inc. Registration Statement on Form S-4 Filed July 22, 2011 File No. 333-175729 Dear Ms. Wray: Please find set forth below the responses of MedAss |
|
| September 30, 2011 |
Exhibit 99.1 Business Segments We deliver our solutions through two business segments, Revenue Cycle Management (?RCM?) and Spend and Clinical Resource Management (?SCM?), which we previously referred to as our Spend Management Segment. Information about our business segments should be read together with ?Management?s Discussion and Analysis of Financial Condition and Results of Operations? and ou |
|
| September 30, 2011 |
Financial Statements and Exhibits, Other Events Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31,2010 Date of Report (Date of Earliest Event Reported): September 29, 2011 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (S |
|
| September 21, 2011 |
September 21, 2011 VIA EDGAR AND FEDERAL EXPRESS Craig D. Wilson Senior Assistant Chief Accountant Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-7010 Re: MedAssets, Inc. Form 10-K for the Fiscal Year Ended December 31, 2010 Filed March 1, 2011 Form 10-Q for the Quarterly Period Ended June 30, 2011 Filed August 8, 2011 File No. 001-33881 Dear Mr. Wilson: Please find set |
|
| September 15, 2011 | ||
| September 7, 2011 |
Exhibit 10.1 MedAssets Separation and Release Agreement PLEASE READ THIS AGREEMENT CAREFULLY; IT INCLUDES A RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS The purpose of this document is to set forth the terms and conditions of the Separation Agreement (the ?Agreement?) between you and MedAssets, Inc. and MedAssets Services, LLC (collectively, the ?Company?) with respect to the termination of your employ |
|
| September 7, 2011 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 6, 2011 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commiss |
|
| September 1, 2011 |
MEDASSETS, INC. 100 North Point Center East, Suite 200 Alpharetta, Georgia 30022 MEDASSETS, INC. 100 North Point Center East, Suite 200 Alpharetta, Georgia 30022 September 1, 2011 VIA EDGAR AND FEDERAL EXPRESS Craig D. Wilson Senior Assistant Chief Accountant Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-7010 Re: MedAssets, Inc. Form 10-K for the Fiscal Year Ended December 31, 2010 Filed March 1, 2011 Form 10-Q for the Quarterly Period Ended June 30 |
|
| August 23, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 23, 2011 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| August 23, 2011 |
MedAssets Announces Share Repurchase Plan Exhibit 99.1 MedAssets Announces Share Repurchase Plan ATLANTA-(BUSINESS WIRE)-August 23, 2011-MedAssets, Inc. (NASDAQ: MDAS) today announced that its Board of Directors has authorized the repurchase of up to $25 million of the company?s Common Stock. The company also announced that it made a $25 million voluntary prepayment on its outstanding term loan in August. ?This share repurchase plan and v |
|
| August 18, 2011 | ||
| August 18, 2011 | ||
| August 8, 2011 |
EX-10.5 6 g27446exv10w5.htm EX-10.5 Exhibit 10.5 EMPLOYMENT AGREEMENT This AMENDED AND RESTATED EMPLOYMENT AGREEMENT is made and entered into as of this 16th day of November 2010, and amended as of this 2nd day of May 2011, by and between MedAssets, Inc., a Delaware corporation (the “Company”), and Lance M. Culbreth (“Employee”). W I T N E S S E T H : WHEREAS, the Company desires to employ Employe |
|
| August 8, 2011 |
EX-10.4 5 g27446exv10w4.htm EX-10.4 Exhibit 10.4 EMPLOYMENT AGREEMENT This AMENDED AND RESTATED EMPLOYMENT AGREEMENT is made and entered into as of this 22nd day of August, 2007, and amended as of this 2nd day of May 2011, by and between MedAssets, Inc., a Delaware corporation (the “Company”), and L. Neil Hunn (“Employee”). W I T N E S S E T H : WHEREAS, the Company desires to employ Employee and |
|
| August 8, 2011 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-33881 MEDASSETS, INC. |
|
| August 8, 2011 |
EX-10.1 2 g27446exv10w1.htm EX-10.1 Exhibit 10.1 EMPLOYMENT AGREEMENT This AMENDED AND RESTATED EMPLOYMENT AGREEMENT is made and entered into as of this 21st day of August, 2007, and amended as of this 2nd day of May 2011, by and between MedAssets, Inc., a Delaware corporation (the “Company”), and John A. Bardis (“Employee”). W I T N E S S E T H : WHEREAS, the Company desires to employ Employee an |
|
| August 8, 2011 |
Exhibit 10.3 EMPLOYMENT AGREEMENT This AMENDED AND RESTATED EMPLOYMENT AGREEMENT is made and entered into as of this 7th day of January 2011, and amended as of this 2nd day of May 2011, by and between MedAssets, Inc., a Delaware corporation (the ?Company?), and Charles Garner (?Employee?). W I T N E S S E T H : WHEREAS, the Company desires to employ Employee and to enter into an agreement embodyin |
|
| August 8, 2011 |
EX-10.2 3 g27446exv10w2.htm EX-10.2 Exhibit 10.2 EMPLOYMENT AGREEMENT This AMENDED AND RESTATED EMPLOYMENT AGREEMENT is made and entered into as of this 22nd day of August, 2007, and amended as of this 2nd day of May 2011, by and between MedAssets, Inc., a Delaware corporation (the “Company”), and Rand Ballard (“Employee”). W I T N E S S E T H : WHEREAS, the Company desires to employ Employee and |
|
| August 1, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 1, 2011 MedAssets, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33881 51-0391128 (State or other jurisdiction of incorporation) (Commission File Num |
|
| August 1, 2011 |
MedAssets Reports Second Quarter and Six-Month 2011 Financial Results Exhibit 99.1 MedAssets Reports Second Quarter and Six-Month 2011 Financial Results ATLANTA-(BUSINESS WIRE)-August 1, 2011-MedAssets, Inc. (NASDAQ: MDAS) today announced results for its second quarter and six months ended June 30, 2011. Second quarter results are summarized in the table below: (In millions, except per share) 2Q-11 2Q-10 a 2Q-10 a,b Net Revenue: Recast Non-GAAP Acquisition- Affected |
|
| July 22, 2011 |
ASPEN HEALTHCARE INFORMATION SERVICES, LLC LIMITED LIABILITY COMPANY AGREEMENT Exhibit 3.6 ASPEN HEALTHCARE INFORMATION SERVICES, LLC LIMITED LIABILITY COMPANY AGREEMENT This Limited Liability Company Agreement (this ?Agreement?) is enacted as of May 5, 2005, by and between Aspen Healthcare Information Services, LLC, a Delaware limited liability company (the ?Company?) and MedAssets, Inc., a Delaware corporation (the ?Member?). WITNESSETH: WHEREAS, the Member has decided to |
|
| July 22, 2011 |
Exhibit 3.14 AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF MEDASSETS SERVICES LLC (FKA MEDASSETS FINANCIAL SERVICES LLC) This Amended and Restated Limited Liability Company Agreement (this ?Agreement?) of MedAssets Services LLC, (the ?Company?) dated as of July 23, 2009 by and among MedAssets, Inc., a Delaware Corporation (the ?Member?), the Member of the Company as provided on the s |
|
| July 22, 2011 |
Exhibit 3.13 State of Delaware Secretary of State Division of Corporations Delivered 01:48 PM 04/18/2007 FILED 01:47 PM 04/18/2007 SRV 070448794 ? 4336500 FILE CERTIFICATE OF FORMATION OF MEDASSETS FINANCIAL SERVICES LLC Under Section 18-201 of the Delaware Limited Liability Company Act This Certificate of Formation of MedAssets Financial Services LLC (the ?Company?), dated as of April 18, 2007 is |
|
| July 22, 2011 |
Exhibit 21.1 Subsidiaries of MedAssets, Inc. State or Other Jurisdiction of Name of Subsidiary Incorporation or Organization Aspen Healthcare Metrics LLC Delaware MedAssets Analytical Systems, LLC Delaware MedAssets Supply Chain Systems, LLC Delaware MedAssets Net Revenue Systems, LLC Delaware Dominic & Irvine, LLC Delaware MedAssets Services, LLC Delaware Broadlane Intermediate Holdings, Inc. Del |
|
| July 22, 2011 |
787 Seventh Avenue New York, NY 10019-6099 Tel: 212 728 8000 Fax: 212 728 8111 787 Seventh Avenue New York, NY 10019-6099 Tel: 212 728 8000 Fax: 212 728 8111 July 22, 2011 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| July 22, 2011 |
BY-LAWS Broadlane Intermediate Holdings, Inc. (A Delaware Corporation) Exhibit 3.16 BY-LAWS of Broadlane Intermediate Holdings, Inc. (A Delaware Corporation) TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 1 ARTICLE 2 STOCKHOLDERS 2 ARTICLE 3 DIRECTORS 7 ARTICLE 4 COMMITTEES OF THE BOARD 9 ARTICLE 5 OFFICERS 9 ARTICLE 6 INDEMNIFICATION 11 ARTICLE 7 GENERAL PROVISIONS 13 i ARTICLE I DEFINITIONS As used in these By-laws, unless the context otherwise requires, the term: 1. |
|
| July 22, 2011 |
CERTIFICATE OF FORMATION Broadlane Ventures, LLC Exhibit 3.19 CERTIFICATE OF FORMATION OF Broadlane Ventures, LLC The undersigned, an authorized natural person, for the purpose of forming a limited liability company, under the provisions and subject to the requirements of the State of Delaware (particularly Chapter 18, Title 6 of the Delaware Code and the acts amendatory thereof and supplemental thereto, and known, identified, and referred to as |
|
| July 22, 2011 |
MEDASSETS SUPPLY CHAIN SYSTEMS, LLC LIMITED LIABILITY COMPANY AGREEMENT Exhibit 3.8 MEDASSETS SUPPLY CHAIN SYSTEMS, LLC LIMITED LIABILITY COMPANY AGREEMENT This Limited Liability Company Agreement (this ?Agreement?) is enacted as of December 19, 2006, for MedAssets Supply Chain Systems, LLC, a Delaware limited liability company (the ?Company?) by MedAssets, Inc., a Delaware corporation (the ?Member?). WITNESSETH: WHEREAS, the Member has decided to form a limited liabi |
|
| July 22, 2011 |
As filed with the Securities and Exchange Commission on July 22, 2011 Table of Contents As filed with the Securities and Exchange Commission on July 22, 2011 Registration No. |
|
| July 22, 2011 |
DOLPHIN ACQUISITION, LLC AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT Exhibit 3.12 DOLPHIN ACQUISITION, LLC AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT This Amended and Restated Limited Liability Company Agreement (this “Agreement”) is enacted as of October 20, 2006, for Dolphin Acquisition, LLC, a Delaware limited liability company (the “Company”) by MedAssets Supply Chain Systems, LLC, a Delaware limited liability company (“MSCS” or the “Member”). WIT |
